About Gland Pharma
Gland Pharma is a company based in Hyderabad (India) founded in 1978 by Ravi Penmetsa and Pvn Raju was acquired by Fosun in July 2016. Gland Pharma has raised $208.59 million across 1 funding round from investors including KKR, Fosun and Gland Celsus Bio Chemicals. The company has 4,350 employees as of March 31, 2024. Gland Pharma has completed 1 acquisition, including Cenexi. Gland Pharma operates in a competitive market with competitors including Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences, ApiJect and August Bioservices, among others.
- Headquarter Hyderabad, India
- Employees 4350 as on 31 Mar, 2024
- Founders Ravi Penmetsa, Pvn Raju
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gland Pharma Ltd.
-
Annual Revenue
$654.31 M (USD)-0.91as on Mar 31, 2025
-
Net Profit
$81.82 M (USD)-9.57as on Mar 31, 2025
-
EBITDA
$149.71 M (USD)-4.24as on Mar 31, 2025
-
Total Equity Funding
$208.59 M (USD)
in 1 rounds
-
Latest Funding Round
$208.59 M (USD), Unspecified
Nov 28, 2013
-
Investors
KKR
& 2 more
-
Employee Count
4350
as on Mar 31, 2024
- Investments & Acquisitions
-
Acquired by
Fosun
(Jul 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gland Pharma
Gland Pharma is a publicly listed company on the NSE with ticker symbol GLAND in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Gland Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Gland Pharma
Gland Pharma has successfully raised a total of $208.59M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $208.59 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gland Pharma
Gland Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Fosun and Gland Celsus Bio Chemicals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Provider of legal, accounting, book keeping, and tax consulting services
|
Locked | Locked | Locked | |
|
Diversified investment, asset management, and insurance services are offered globally.
|
Locked | Locked | Locked |
Investor details for Gland Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gland Pharma
Gland Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cenexi.
Investment portfolio details for Gland Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pre-formulation and formulation services are provided in pharmaceuticals.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Gland Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Gland Pharma
Detailed financials for Gland Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gland Pharma Comparisons
Peer comparison for Gland Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gland Pharma
Gland Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences, ApiJect and August Bioservices, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of pharmaceutical products
|
|
| Locked | Locked | Locked |
Nasal spray drug products are developed, manufactured, and commercialized.
|
|
| Locked | Locked | Locked |
Medicine injectors are manufactured by ApiJect for medical applications.
|
|
| Locked | Locked | Locked |
Diversified research services for clinical solutions are offered.
|
Detailed competitors of Gland Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gland Pharma
Complete news archive for Gland Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gland Pharma
Gland Pharma was founded in 1978 and raised its 1st funding round 35 years after it was founded.
Gland Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Srinivas Sadu is the current CEO of Gland Pharma.
Gland Pharma is a funded company, having raised a total of $208.59M across 1 funding round to date.
As of Mar 31, 2024, the latest employee count at Gland Pharma is 4,350.
Annual revenue of Gland Pharma is $654.31M as on Mar 31, 2025.
The company was founded in 1978 in Hyderabad, India, and operates in the pharmaceutical sector as a manufacturer of generic injectable drugs. A portfolio of products has been established in sterile injectables, oncology, and ophthalmics, with emphasis on complex injectables and various delivery systems. Diverse injectable needs are addressed through a stable supply chain, serving global markets from its base in India.
Gland Pharma's top competitors include Exela Pharma, Luoxin Pharmaceutical Group and Summit Biosciences.
Yes, Gland Pharma is publicly traded on NSE under the ticker symbol GLAND.
Gland Pharma has made 1 acquisition, including Cenexi.
Gland Pharma has 3 investors. Key investors include KKR, Fosun, and Gland Celsus Bio Chemicals.
The ticker symbol of Gland Pharma is GLAND on NSE.
The valuation of Gland Pharma is $445.93M as of Nov 2013.